23 related articles for article (PubMed ID: 38449350)
21. Tumor immune microenvironment in odontogenic carcinomas: Evaluation of the therapeutic potential of immune checkpoint blockade.
Oh KY; Hong SD; Yoon HJ
J Oral Pathol Med; 2024 Mar; 53(3):217-225. PubMed ID: 38449350
[TBL] [Abstract][Full Text] [Related]
22. Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade.
Budimir N; Thomas GD; Dolina JS; Salek-Ardakani S
Cancer Immunol Res; 2022 Feb; 10(2):146-153. PubMed ID: 34937730
[TBL] [Abstract][Full Text] [Related]
23. Immunological Mechanisms behind Anti-PD-1/PD-L1 Immune Checkpoint Blockade: Intratumoral Reinvigoration or Systemic Induction?
Guo Z; Yu J; Chen Z; Chen S; Wang L
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672120
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
